Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Clinical Microbiology Reviews · 13.06.2024 · 37 (2)
DOI: 10.1128/cmr.00074-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.06.2024. Verfasst von Martin Hoenigl und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Medical University of Graz, Graz, Aust…. Hauptthemen laut MEDLINE: Antifungal Agents, Invasive Fungal Infections, Drug Resistance, Fungal. Die Arbeit wurde bisher 159-mal zitiert (Crossref) und nennt 502 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Fungal infections are on the rise, driven by a growing population at risk and climate change. Currently available antifungals include only five classes, and their utility and efficacy in antifungal treatment are limited by one or more of innate or acquired resistance in some fungi, poor penetration into “sequestered” sites, and agent-specific side effect which require frequent patient reassessment and monitoring. Agents with novel mechanisms, favorable pharmacokinetic (PK) profiles including good oral bioavailability, and fungicidal mechanism(s) are urgently needed. Here, we provide a comprehensive review of novel antifungal agents, with both improved known mechanisms of actions and new antifungal classes, currently in clinical development for treating invasive yeast, mold (filamentous fungi), Pneumocystis jirovecii infections, and dimorphic fungi (endemic mycoses). We further focus on inhaled antifungals and the role of immunotherapy in tackling fungal infections, and the specific PK/pharmacodynamic profiles, tissue distributions as well as drug-drug interactions of novel antifungals. Finally, we review antifungal resistance mechanisms, the role of use of antifungal pesticides in agriculture as drivers of drug resistance, and detail detection methods for antifungal resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Medical University of Graz, Graz, Austria.
- BiotechMed-Graz, Graz, Austria.
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
- Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
- Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Martin Hoenigl, Maiken Cavling Arendrup, Roger Brüggemann, Agostinho Carvalho, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frédéric Lamoth, Sarah Sedik, Nathan P Wiederhold, George R Thompson
Zitieren
APA
Hoenigl, M., Arastehfar, A., Arendrup, M. C., Brüggemann, R., Carvalho, A., Chiller, T., Chen, S., Egger, M., Feys, S., Gangneux, J. P., Gold, J. A. W., Groll, A. H., Heylen, J., Jenks, J. D., Krause, R., Lagrou, K., Lamoth, F., Prattes, J., Sedik, S., …, & Thompson, G. R. (2024). Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical Microbiology Reviews, 37(2). https://doi.org/10.1128/cmr.00074-23
Vancouver
Hoenigl M, Arastehfar A, Arendrup MC, Brüggemann R, Carvalho A, Chiller T, et al. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical Microbiology Reviews. 2024;37(2). doi:10.1128/cmr.00074-23
BibTeX
@article{Hoenigl2024,
author = {Hoenigl, Martin and Arastehfar, Amir and Arendrup, Maiken Cavling and Brüggemann, Roger and Carvalho, Agostinho and Chiller, Tom and Chen, Sharon and Egger, Matthias and Feys, Simon and Gangneux, Jean-Pierre and Gold, Jeremy A W and Groll, Andreas H and Heylen, Jannes and Jenks, Jeffrey D and Krause, Robert and Lagrou, Katrien and Lamoth, Frédéric and Prattes, Juergen and Sedik, Sarah and Wauters, Joost and Wiederhold, Nathan P and Thompson, George R},
title = {Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease},
journal = {Clinical Microbiology Reviews},
year = {2024},
volume = {37},
number = {2},
doi = {10.1128/cmr.00074-23}
}
EUVIMED